crude oil

U.S. benchmarks held ground overnight after reversing sharply on news California rolled back its reopening. both JPMorgan and Citigroup are trading higher after beats.
The FDA granted Pfizer and BionTech fast-track designation for their Covid-19 vaccine candidates. The news helped push the indices broadly out above their overnight ranges.
U.S. stocks got a boost from overnight price action in Europe and Asia, and continued higher after positive ISM and PMI numbers early this morning.
With a new quarter upon us and a holiday session Friday, it begs the question whether stocks will now see outflows. It would be smart for investors to reduce exposure, even marginally, and still be happy if the S&P marches to 3525 in the coming months.
U.S. benchmarks are unchanged ahead of the bell after grinding out a strong close yesterday. The S&P 500 index traded to a new low overnight, ahead of Thursday’s session, and held the retest at the open.
U.S. benchmarks were roiled yesterday as Covid-19 cases surged by roughly 35,000, the most since April.
After a soft finish yesterday, selling pressure kicked in on the European open due to reports the White House is considering additional tariffs on the E.U. and U.K.
U.S. benchmarks pointed higher ahead of the bell despite a quick whipsaw early last night.
On Friday’s quadruple witching, U.S. benchmarks posted session highs at the opening bell upon the expiration of June futures and options.
Quadruple witching typically brings volatility in its aftermath as positions are unwound. Ahead of the Federal Reserve meeting last week, we called for this date to bring a cleansing.